-
公开(公告)号：US11033537B2
公开(公告)日：2021-06-15
申请号：US16915562
申请日：2020-06-29
IPC分类号： A61K31/444 , C07K16/28 , A61K39/395 , A61K45/06 , A61P35/00 , A61K39/00
摘要： The present invention provides, inter alia, a composition containing a compound of formula (I): or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provided herein.
-
公开(公告)号：US10716782B2
公开(公告)日：2020-07-21
申请号：US16692560
申请日：2019-11-22
IPC分类号： A61K31/444 , C07K16/28 , A61K39/395 , A61K45/06 , A61P35/00 , A61K39/00
摘要： The present invention provides, inter alia, a composition containing a compound of formula (I): or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provided herein.
-
3.发明申请LPT-723 AND IMMUNE CHECKPOINT INHIBITOR COMINATIONS AND METHODS OF TREATMENT 有权LPT-723和免疫检查点抑制剂的研究和治疗方法公开(公告)号：US20170007587A1
公开(公告)日：2017-01-12
申请号：US15195723
申请日：2016-06-28
IPC分类号： A61K31/444 , A61K39/395 , C07K16/28
CPC分类号： A61K31/444 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/507 , C07K16/2818 , C07K2317/76 , A61K2300/00
摘要： The present invention provides, inter alia, a composition containing a compound of formula (I): or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provided herein.
摘要翻译： 或其药学上可接受的盐，任选地与至少一种免疫检查点抑制剂化合物组合。 本文还提供了含有该组合物的试剂盒，以及使用该组合物改善或治疗患者疾病如癌症的效果的方法。
-
公开(公告)号：US20200323831A1
公开(公告)日：2020-10-15
申请号：US16915562
申请日：2020-06-29
IPC分类号： A61K31/444 , C07K16/28 , A61K39/395 , A61K45/06 , A61P35/00
摘要： The present invention provides, inter alia, a composition containing a compound of formula (I): or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provided herein.
-
公开(公告)号：US20180117020A1
公开(公告)日：2018-05-03
申请号：US15809759
申请日：2017-11-10
IPC分类号： A61K31/444 , A61K45/06 , A61K39/395
CPC分类号： A61K31/444 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/507 , A61P35/00 , C07K16/2818 , C07K2317/76 , A61K2300/00
摘要： The present invention provides, inter alia, a composition containing a compound of formula (I): or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provided herein.
-
公开(公告)号：US20200078342A1
公开(公告)日：2020-03-12
申请号：US16692560
申请日：2019-11-22
IPC分类号： A61K31/444 , A61K39/395 , A61K45/06 , C07K16/28 , A61P35/00
摘要： The present invention provides, inter alia, a composition containing a compound of formula (I): or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provided herein.
-
公开(公告)号：US09861621B2
公开(公告)日：2018-01-09
申请号：US15195723
申请日：2016-06-28
IPC分类号： A61K31/44 , A61K31/444 , C07K16/28 , A61K39/395 , A61K45/06 , A61K39/00
CPC分类号： A61K31/444 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61K2039/507 , C07K16/2818 , C07K2317/76 , A61K2300/00
摘要： The present invention provides, inter alia, a composition containing a compound of formula (I): or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provided herein.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.016 秒)
